Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
- PMID: 28570530
- PMCID: PMC5608001
- DOI: 10.3791/55741
Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
Abstract
We have previously reported on the generation of plasma membrane vesicles (PMVs) through the mechanical extrusion of mammalian cells. The fusion of PMVs with mitochondrial deficient Rho0 cells restored mitotic activity under normal culture conditions. Atherosclerosis, type 2 diabetes, Alzheimer's disease, and cancer are age-related diseases that have been reported to be associated with multiple mechanical and functional defects in the cytosol and organelles of a variety of cell types. Bone marrow mesenchymal stem cells (BMSCs) represent a unique cell population from the bone marrow that possess self-renewal capabilities while maintaining their multipotency. The supplementation of senescence cells with young cytoplasm from autologous BMSCs via the fusion of PMVs provides a promising approach to ameliorate or even reverse age-associated phenotypes. This protocol describes how to prepare PMVs from BMSCs via extrusion through a polycarbonate membrane with 3 µm pores, determine the existence of mitochondria and examine the maintenance of membrane potential within PMVs using a confocal microscope, concentrate PMVs by centrifugation, and carry out the in vivo injection of PMVs into the gastrocnemius muscle of mice.
Similar articles
-
Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy.Stem Cell Res Ther. 2020 Jun 8;11(1):225. doi: 10.1186/s13287-020-01738-z. Stem Cell Res Ther. 2020. PMID: 32513263 Free PMC article.
-
Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria.Biomed Microdevices. 2016 Jun;18(3):41. doi: 10.1007/s10544-016-0066-y. Biomed Microdevices. 2016. PMID: 27165101
-
Ectopic bone regeneration by human bone marrow mononucleated cells, undifferentiated and osteogenically differentiated bone marrow mesenchymal stem cells in beta-tricalcium phosphate scaffolds.Tissue Eng Part C Methods. 2012 Jul;18(7):545-56. doi: 10.1089/ten.TEC.2011.0470. Epub 2012 Feb 22. Tissue Eng Part C Methods. 2012. PMID: 22250840
-
Red cell PMVs, plasma membrane-derived vesicles calling out for standards.Biochem Biophys Res Commun. 2010 Sep 3;399(4):465-9. doi: 10.1016/j.bbrc.2010.07.095. Epub 2010 Jul 30. Biochem Biophys Res Commun. 2010. PMID: 20674549 Review.
-
Molecular characterisation of plasma membrane-derived vesicles.J Biomed Sci. 2015 Aug 11;22(1):68. doi: 10.1186/s12929-015-0174-7. J Biomed Sci. 2015. PMID: 26259622 Free PMC article. Review.
Cited by
-
Plasma membrane vesicles of human umbilical cord mesenchymal stem cells ameliorate acetaminophen-induced damage in HepG2 cells: a novel stem cell therapy.Stem Cell Res Ther. 2020 Jun 8;11(1):225. doi: 10.1186/s13287-020-01738-z. Stem Cell Res Ther. 2020. PMID: 32513263 Free PMC article.
-
Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation.Front Immunol. 2019 Nov 15;10:2663. doi: 10.3389/fimmu.2019.02663. eCollection 2019. Front Immunol. 2019. PMID: 31849929 Free PMC article. Review.
-
Protective Effects of Rat Bone Marrow Mesenchymal Stem Cells-Derived Fusogenic Plasma Membrane Vesicles Containing VSVG Protein Mediated Mitochondrial Transfer on Myocardial Injury In Vitro.FASEB Bioadv. 2025 Apr 15;7(5):e70010. doi: 10.1096/fba.2024-00235. eCollection 2025 May. FASEB Bioadv. 2025. PMID: 40330432 Free PMC article.
-
Fibroblasts as Turned Agents in Cancer Progression.Cancers (Basel). 2023 Mar 28;15(7):2014. doi: 10.3390/cancers15072014. Cancers (Basel). 2023. PMID: 37046676 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources